General Info

Interleukin Genetics is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, the company uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin was established as one of the only companies that developed a DNA-based risk assessment test that could warn people of whether or not they have a genetic risk factor that affected how their body uses the inflammatory response, an important risk factor for heart disease. It also markets a nutritional product specifically defined for people who have tested positive for certain interleukin 1 genetic variations. Interleukin Genetics maintains a location in Waltham, Mass.